MedPath

Study in Tohoku Preventive Effect of Camostat on Progression of Chronic Pancreatitis

Not Applicable
Conditions
chronic pancreatitis recurrent pancreatitis alcoholic acute pancreatitis
Registration Number
JPRN-UMIN000001056
Lead Sponsor
Tohoku University Graduate School of Medicine Division of Gastroenterology
Brief Summary

unpublished

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients under 20 years old. 2) Patients with contraindications to Foipan or Berizym. 3) Patients scheduled for surgery, endoscopic treatment, or extracorporeal shock wave lithotripsy(ESWL) as treatment for pancreatitis. 4) Patients whom the attending doctor consider inappropiate to participate in this clinical study for some reason.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath